Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefuroxime vs Ampicillin Prophylaxis in PPROM
NCT02819570Phase 4Unknown
- Sponsor
- Galilee Medical Center
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefuroxime in preterm premature rupture of membranes (pPROM), sponsored by Galilee Medical Center. Status: unknown.
02
Drugs
cefuroxime
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT02819570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819570.